small-cap

Should you sell Mantra Group now?

Dec 20, 2017 | Team Kalkine
Should you sell Mantra Group now?


MTR Details

Mantra Group, the leading Australian-based hotel and resort operator, has been performing well with rising demand in travel and tourism sector. The group has been growing well since listing in 2014 and has witnessed a three-year CAGR for underlying EBITDAI at 18.2%. FY17 also has been a strong year with all operating segments on track and performing in line with market guidance. MTR’s portfolio has grown by 6 new properties in the fiscal year 2017 and additional 3 properties since 30 June, namely Mantra Sydney Airport Hotel, FV by Peppers in Brisbane and Mantra MacArthur Hotel, Canberra were added. The group’s acquisition of the Art Series Hotel Group delivered 7 unique CBD hotels into Mantra’s growing portfolio.
 

Performance over the Years (Source: Company Reports) 

Around mid-December, Credit Suisse became a substantial holder with 5.07% interests in MTR.

Taking advantage of the tourism sector trends, MTR has gained a lot of attention with French hotel giant, AccorHotels inking an agreement with Mantra for acquiring all of the issued capital in Mantra by way of a scheme of arrangement while offering AUD3.96 in cash for each Mantra share including any potential special dividend. The offer is $4.02 per share less the final FY17 dividend that has already been paid. Further, the acquisition looks to be over 10% EPS accretive. If approved by regulators, the deal will be finalised by April 2018. As of now, the deal has moved to the next stage for the review by the Australian Competition and Consumer Commission late in November 2017.

It is worth noting that the acquisition move has been based on Mantra’s ability to identify and secure sizeable assets, FY17 performance with 17 acquisitions and better profits, and the trend in tourism sector which may witness a double-digit growth in international visitors over next year.

While there can be some upside potential; considering the current scenario on acquisition and regulatory risks pertaining to combined market share of Accor and MTR with a slightly uncertain market impact and any additional risks around project deferments / cancellations, we put a “Sell” on the stock at the current price of $3.90


MTR Daily Chart (Source: Thomson Reuters)
 



Disclaimer
 
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Past performance is not a reliable indicator of future performance.